首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >The Effect of Pudilan Anti-Inflammatory Oral Liquid on the Treatment of Mild Recurrent Aphthous Ulcers
【2h】

The Effect of Pudilan Anti-Inflammatory Oral Liquid on the Treatment of Mild Recurrent Aphthous Ulcers

机译:普地兰消炎口服液治疗轻度复发性口疮的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recurrent aphthous ulcers are the most common recurrent oral mucosal lesions characterized by recurrence and pain. The aim of this research is to evaluate the short-term curative effect of the traditional Chinese medicine “Pudilan anti-inflammatory oral liquid” on mild recurrent aphthous ulcers. A total of 234 patients were divided into a treatment group and a control group. Both groups used vitamin B2 as the basis of treatment. The treatment group took a Pudilan anti-inflammatory oral solution for 8 days while the control group was given a liquid placebo. The ulcer size, pseudomembrane, peripheral congestion, and pain scores of the treatment group were lower than before treatment. The curative effect on the Pudilan group was statistically significant compared with the control group. The final therapeutic effect on the treatment group was better than that on the control group. The healing time of mild recurrent aphthous ulcers can be shortened by Pudilan anti-inflammatory oral liquid, and pain is relieved without adverse reactions. Pudilan provides a new reference drug for the treatment of mild recurrent oral ulcers.
机译:复发性口疮是最常见的复发性口腔粘膜病变,其特征是复发和疼痛。这项研究的目的是评估中药“普地兰消炎口服液”对轻度复发性口疮的近期疗效。总共234例患者被分为治疗组和对照组。两组均使用维生素B2作为治疗基础。治疗组服用普地兰抗炎口服溶液8天,而对照组则给予液体安慰剂。治疗组溃疡大小,假膜,周围充血和疼痛评分均低于治疗前。与对照组相比,普地兰组的疗效具有统计学意义。治疗组的最终治疗效果优于对照组。普地兰抗炎口服液可以缩短轻度复发性口疮的愈合时间,并且可以缓解疼痛而无不良反应。普地兰提供了一种治疗轻度复发性口腔溃疡的新参考药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号